1994
DOI: 10.1016/s0021-9258(17)34082-6
|View full text |Cite
|
Sign up to set email alerts
|

Functional alpha-tropomyosin produced in Escherichia coli. A dipeptide extension can substitute the amino-terminal acetyl group.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
60
0

Year Published

1997
1997
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 218 publications
(64 citation statements)
references
References 38 publications
4
60
0
Order By: Relevance
“…Interactions of human tropomyosin isoforms Tpm1.1 and Tpm3.12, specific for fast and slow skeletal muscle fibers, with F-actin were analyzed in vitro by using a co-sedimentation assay. Both isoforms were recombinant proteins carrying Ala-Ser N-terminal extension, which compensated for the lack of the N-terminal acetylation, typical for proteins expressed in bacterial cells [35]. Binding of both isoforms to actin was analyzed before, but under different salt concentrations [36,37].…”
Section: Binding Of Human Tpm11 and Tpm312 To F-actinmentioning
confidence: 99%
See 1 more Smart Citation
“…Interactions of human tropomyosin isoforms Tpm1.1 and Tpm3.12, specific for fast and slow skeletal muscle fibers, with F-actin were analyzed in vitro by using a co-sedimentation assay. Both isoforms were recombinant proteins carrying Ala-Ser N-terminal extension, which compensated for the lack of the N-terminal acetylation, typical for proteins expressed in bacterial cells [35]. Binding of both isoforms to actin was analyzed before, but under different salt concentrations [36,37].…”
Section: Binding Of Human Tpm11 and Tpm312 To F-actinmentioning
confidence: 99%
“…Human Tpm1.1 and Tpm3.12 isoforms were expressed in BL21 (DE3) cells (Novagen Inc, Affiliate of Merck KGaA, Darmstadt, Germany) and purified as described before [37,39]. The sequence of both isoforms was identical with the human Tpm1.1 and Tpm3.12, except for two amino acid extension (Ala-Ser), which is routinely used to compensate for the lack of the N-terminal acetylation in the recombinant proteins expressed in bacterial cells [35]. Protein concentration was determined spectrophotometrically at 280 nm using molar extinction coefficient 17,880.…”
Section: Preparation Of Recombinant Tropomyosin Isoforms and Cofilin-2mentioning
confidence: 99%
“…Another possible explanation for very low actin affinity of the Tpm1.12 was that its C-terminal residues for some reason could not normally interact with non-acetylated N-terminus. To check this assumption, we produced recombinant Tpm1.12 that had an Ala-Ser N-terminal extension mimicking N-terminal acetylation of Tpm [40]. It was shown earlier that recombinant α-Tpm (Tpm1.1) expressed in E. coli loses N-terminal acetylation and cannot bind actin, while Ala-Ser N-terminal extension fully restores the Tpm ability to interact with actin [40].…”
Section: 1mentioning
confidence: 99%
“…To check this assumption, we produced recombinant Tpm1.12 that had an Ala-Ser N-terminal extension mimicking N-terminal acetylation of Tpm [40]. It was shown earlier that recombinant α-Tpm (Tpm1.1) expressed in E. coli loses N-terminal acetylation and cannot bind actin, while Ala-Ser N-terminal extension fully restores the Tpm ability to interact with actin [40]. We confirmed, using MALDI-TOF mass-spectrometry, the presence of Ala-Ser N-terminal extension in this Tpm.12 sample and performed cosedimentation experiments to investigate its affinity for actin.…”
Section: 1mentioning
confidence: 99%
See 1 more Smart Citation